Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 01, 2005 (Vol. 25, No. 9)

Gymnosperm Database Home Page

URL:home.earthlink.net/~earlecj
  • Simple design
  • Restricted audience
Established in the summer of 1997 by Christopher Earle, the Gymnosperm Database is about what you'd expect-a site full of information about conifers and related trees. Navigaton is simple . Users move quickly through the site using hyperlinks and the opening page provides a search engine for easy access to all the information on the site. The Gymnosperm Database appears to be a one person operation. Looking at the great breadth of coverage at the site (family descriptions along with pictures, an eclectic list of topics-Gymnosperms of New Caledonia, an extensive list of citations, and a very nice collection of links outside sites), I appload the effort of Christopher and encourage him to keep up the good work.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »